Calithera Biosciences, Inc.·4

Oct 29, 6:51 PM ET

Orford Keith 4

4 · Calithera Biosciences, Inc. · Filed Oct 29, 2021

Insider Transaction Report

Form 4
Period: 2021-10-27
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
  • Award

    Common Stock

    2021-10-27+90,000166,094 total
Footnotes (1)
  • [F1]The shares of Common Stock were acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION